The Associate Director, Late Stage Global Health Economics and Outcomes Research (HEOR), Europe position functions within the Global HEOR group and will serve as a technical and strategic contributor for one or more assets across various therapy areas in the Teva portfolio.
The position will report to the Director, Late Stage Global HEOR.
In accordance with Teva’s regulatory and governance requirements, develop and implement pre and post launch evidence generation plans that represent evidence needs in the EU (regional and local), including clinical, economic, and humanistic evidence that inform and contribute to the overall program strategies for one or more assets across key therapy areas in the Teva portfolio.
Under the supervision of the supervisor, and for specific assets, collaborate to ensure that EU regional and local post-launch evidence needs are incorporated in and are congruent with Global Medical and Commercial strategies.
The AD may need to act as a liaison between individual market colleagues and GHEOR, and other global functions. Input includes providing guidance and input on Phase 3b / 4 studies and post-hoc analyses, and post-launch (RWE) study design from a EU HEOR perspective and ensure inclusion of appropriate PRO and health economic endpoints into these, as necessary.
Working closely with EU market access and relevant market-specific colleagues, understand the value evidence requirements, and under the supervisor’s leadership, contribute to relevant HEOR deliverables to HTA submissions to appropriately support asset launch(es) in the EU.
Contribute to EU payer value and brand team(s) on specific ways in which the EU evidence generation plan may be improved and optimized to facilitate informed decision making including comparative effectiveness.
Keep abreast of the trends in assigned therapeutic areas, HEOR, Pricing, Reimbursement, Real-World Evidence, and Market Access across the EU region and proactively address HEOR strategy changes in collaboration with Global teams in anticipation of these trends.
Collaborate closely and align in a cross-functional matrix team environment and effectively design, execute, and effectively communicate relevant HEOR study results to internal and external audiences.
Qualifications and Experience
Master's Degree in Health Economics, Epidemiology, Health Services Research or a related field.
Demonstrable experience of relevant Pharmaceutical / biotechnology / academic / governmental agency experience.
Track record of peer-reviewed scientific publications demonstrating expertise in EU HEOR at the local and / or regional level
Comprehensive knowledge of own core discipline and good working knowledge of health care systems and health technology assessment guidelines and processes in relevant EU countries.
Ability to understand disease space and appropriately plan and deliver HEOR strategy and studies for specific assets. Serve as source of expertise / advice in epidemiology, outcomes research, health economics, health policy for cross-functional team members.
Experience with EU HTA submissions
Already Working TEVA?
If you are a current Teva employee, please apply using the internal career site available on "Employee Central". By doing so, your application will be treated with priority.
You will also be able to see opportunities that are open exclusively to Teva employees. Use the following link to search and apply :
The internal career site is available from your home network as well. If you have trouble accessing your EC account, please contact your local HR / IT partner.
Teva’s Equal Employment Opportunity Commitment
Teva Pharmaceuticals is committed to equal opportunity in employment. It is Teva's global policy that equal employment opportunity be provided without regard to age, race, creed, color, religion, sex, disability, pregnancy, medical condition, sexual orientation, gender identity or expression, ancestry, veteran status, national or ethnic origin or any other legally recognized status entitled to protection under applicable laws.